Article
Author(s):
Montreal--Using a high-powered potassium titanyl phosphate (KTP) laser to vaporize prostate tissue is proving to be safe and effective as a treatment for urinary retention in men.
Pivotal data for lumasiran in PH1 published in NEJM
Nedosiran explored in primary hyperoxaluria type 3
Enrollment completed in pivotal trial of nedosiran for hyperoxaluria
FDA approves androgen inhibitor for metastatic PCa
Blood test could guide treatment for kidney cancer
BCG for bladder cancer in short supply
Sintilimab plus fruquintinib under review in China for advanced renal cell carcinoma
Data supports mitomycin plus BCG as alternative to BCG alone in NMIBC
Zanzalintinib plus nivolumab shows safety, efficacy for stage 4 RCC
GLP-1 agonist use is rising in men with prostate cancer